Travel medicine providers’ opinions on the dengue vaccine TAK-003 as a travel vaccine and the need for decision-support information and materials before its launch in Japan
TAK-003 is a dengue vaccine introduced in dengue-endemic countries and considered for travelers. Although not yet approved in Japan, inquiries from travelers are increasing. With limited evidence about vaccine use for travelers, consolidated expert opinions would aid in vaccination decision-making....
Saved in:
| Main Authors: | Atsuko Fukunishi, Masaki Machida, Shinji Fukushima, Shigeru Inoue |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2483560 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dengue Vaccine Development and Deployment into Routine Immunization
by: Annelies Wilder-Smith, et al.
Published: (2025-04-01) -
TAK-003: development of a tetravalent dengue vaccine
by: Xavier Sáez-Llorens, et al.
Published: (2025-12-01) -
TAK003 dengue vaccine: A promising tool for dengue control
by: Nitika Nitika, et al.
Published: (2024-11-01) -
A Methodological Approach to Measuring the Impact of TAK-003 for the Prevention of Dengue in Dourados, Brazil: Optimizing Strategies for Public Health
by: Benedetta Ghezzi, et al.
Published: (2025-01-01) -
Role of the dengue vaccine TAK-003 in an outbreak response: Modeling the Sri Lanka experience.
by: LakKumar Fernando, et al.
Published: (2024-08-01)